- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Poor minorities delayseeking needed mammo
A recent study hints that by lowering accessbarriers to mammography, the governmentcould offset the tendency of uninsuredminority women to delay seeking medicalhelp, including mammography.
A recent study hints that by lowering access barriers to mammography, the government could offset the tendency of uninsured minority women to delay seeking medical help, including mammography.
University of North Carolina researchers looked at the correlation between the insurance status of 617 breast cancer patients and the stage and size of their tumors at the time of diagnosis. They found that uninsured non-Caucasian patients have a higher probability of presenting with a more advanced cancer stage and larger tumor size than insured patients. They published their results in Academic Radiology (2008;15[10]: 1255-1258). Dr.Wende Logan-Young, director of the Elizabeth Wende Breast Clinic in Rochester, NY, confirmed that uninsured minority women are less likely than other atrisk populations to undergo screening mammography. An effort by the Obama administration to cover uninsured U.S. residents could change this trend, she said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
